| abstract |
Useful as an inhibitor of protein kinase C-theta (PKC-θ) for the treatment of autoimmune diseases, inflammatory diseases or proliferative or hyperproliferative diseases related to PKC-θ activation Providing compounds and methods of preparing the compounds. A compound typified by N-((4-aminocyclohexyl) methyl) -6- (1H-pyrazolo [3,4-b] pyridin-3-yl) pyridin-2-amine, and the pyrazolo [ Provision of a method for preparing a 3,4-b] pyridine compound. [Selection figure] None |